Abiomed
ABMD
#1073
Rank
NZ$30.70 B
Marketcap
$681.04
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Market capitalization of Abiomed (ABMD)

Last known market cap: NZ$30.70 Billion

On August 1, 2024 Abiomed had a market cap of NZ$30.70 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Abiomed from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$30.46 B12.13%
2023NZ$27.16 B0.4%
2022NZ$27.06 B13.11%
2021NZ$23.92 B17.83%
2020NZ$20.30 B77.69%
2019NZ$11.42 B-47.66%
2018NZ$21.83 B87.13%
2017NZ$11.66 B65.34%
2016NZ$7.05 B26.06%
2015NZ$5.59 B180.53%
2014NZ$1.99 B54.21%
2013NZ$1.29 B103.71%
2012NZ$0.63 B-30.4%
2011NZ$0.91 B93.57%
2010NZ$0.47 B4.64%
2009NZ$0.45 B-56.48%
2008NZ$1.03 B56.53%
2007NZ$0.66 B23.49%
2006NZ$0.53 B50.25%
2005NZ$0.35 B-25.23%
2004NZ$0.47 B109.05%
2003NZ$0.22 B56.05%
2002NZ$0.14 B-81.65%
2001NZ$0.79 B-29.59%
2000NZ$1.13 B84.82%
1999NZ$0.61 B280.33%
1998NZ$0.16 B-33.34%
1997NZ$0.24 B101.46%
1996NZ$0.11 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$14.86 B-51.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$235.45 B 666.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.64 B-91.37%๐Ÿ‡บ๐Ÿ‡ธ USA